Anzeige
Mehr »
Sonntag, 30.08.2026 - Börsentäglich über 12.000 News
Kupfer auf Rekordhoch: Bohrkern unterm Mikroskop - bei dieser Kupfer-Aktie könnte jetzt das Labor den wichtigen Unterschied machen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrStifel reiterates Buy on Autodesk stock, keeps $285 price target
FrStifel reiterates Marvell stock Buy rating on data center strength
FrStifel reiterates Buy rating on Now Inc stock, $19 target
FrStifel cuts Lucky Strike Entertainment stock price target on weak results
FrStifel raises Workday stock price target on AI adoption growth
FrNewtyn Management cuts stake in Pinewood Technologies to 4.79%
FrXTEND delivers M6F surveillance systems to Asia-Pacific customer
FrRezolve Ai partners with Tech Mahindra on commerce deployment
FrBlack Rock Coffee Bar opens new Tucson location
FrBioLineRx raises $3.75 million in registered direct offering
FrEurocommercial H1 2026 slides: Italy drives growth, shares dip on timing
FrBarclays reduces stake in Central Asia Metals to 5.48%
FrENvue Medical announces 1-for-12 reverse stock split
FrLyntris completes thermal management facility in Maryland
FrStifel raises Elastic stock price target to $107 on strong growth
FrAllstate stock rating cut to hold by Argus on valuation
FrArgus raises CrowdStrike stock price target to $425 on strong growth
FrUBS reiterates Dollar General stock rating citing traffic growth
FrArgus upgrades Moderna stock rating on vaccine portfolio strength
FrUBS reiterates Buy on Marvell stock, keeps $310 price target
FrUBS lowers Ulta Beauty stock price target on margin pressures
FrUBS raises SentinelOne stock price target to $24 on strong results
FrUBS raises Elastic stock price target to $105 on cloud growth
FrUBS raises Dollar Tree stock price target to $150 on strategy gains
FrAprea Therapeutics reports patent portfolio of 58 patents